Erratum to “Postoperative Adjuvant and Salvage Radiotherapy for Prostate Cancer: Impact on Freedom From Biochemical Relapse and Survival” (Urology (2004) 64(5) (982–986) (S0090429504007332) (10.1016/j.urology.2004.06.020));Postoperative adjuvant and salvage radiotherapy for prostate cancer: Impact on freedom from biochemical relapse and survival

Urology

Volumn 64, Issue 5, 2004, Pages 982-986

  Pacholke, Heather D ^a   Wajsman, Zev ^a   Algood, Chester B ^a   Morris, Christopher G ^a   Zlotecki, Robert A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD CHEMISTRY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; HIGH RISK PATIENT; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 7944223173     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2017.10.013     Document Type: Erratum

References (25)

1. C.R. Pound, A.W. Partin, J.I. Epstein Prostate-specific antigen after anatomic radical retropubic prostatectomy patterns of recurrence and cancer control Urol Clin North Am 24 1997 395 406
2. M. Ohori, T.M. Wheeler, M.W. Kattan Prognostic significance of positive surgical margins in radical prostatectomy specimens J Urol 154 1995 1818 1824
3. W.J. Catalona, D.S. Smith 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer J Urol 152 1994 1837 1842
4. H. Zincke, J.E. Oesterling, M.L. Blute Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer J Urol 152 1994 1850 1857
5. J.G. Trapasso, J.B. deKernion, R.B. Smith The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy J Urol 152 1994 1821 1825
6. A. Stein, J.B. deKernion, R.B. Smith Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer J Urol 147 1992 942 946
7. M.S. Anscher, L.R. Prosnitz Multivariate analysis of factors predicting local relapse after radical prostatectomy--possible indications for postoperative radiotherapy Int J Radiat Oncol Biol Phys 21 1991 941 947
8. J.I. Epstein, G. Pizov, P.C. Walsh Correlation of pathologic findings with progression after radical retropubic prostatectomy Cancer 71 1993 3582 3593
9. SAS Institute Inc SAS OnlineDoc®, version 8 1999 SAS Institute Inc Cary, NC
10. E.L. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
11. D.R. Cox Regression models and life tables--series B (methodological) J R Stat Soc 34 2004 187 220
12. M.M. Morris, K.C. Dallow, A.L. Zietman Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer Int J Radiat Oncol Biol Phys 38 1997 731 736
13. R. Choo, G. Hruby, J. Hong (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy Int J Radiat Oncol Biol Phys 53 2002 269 276
14. S.E. Schild Radiation therapy (RT) after prostatectomy the case for salvage therapy as opposed to adjuvant therapy Int J Cancer 96 2001 94 98
15. T. Do, G. Dave, R. Parker Serum PSA evaluations during salvage radiotherapy for post-prostatectomy biochemical failures as prognosticators for treatment outcomes Int J Radiat Oncol Biol Phys 50 2001 1220 1225
16. M.S. Anscher, R. Clough, R. Dodge Radiotherapy for a rising prostate-specific antigen after radical prostatectomy the first 10 years Int J Radiat Oncol Biol Phys 48 2000 369 375
17. A.K. Chawla, H.K. Thakral, A.L. Zietman Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma analysis of efficacy and prognostic factors Urology 59 2002 726 731
18. R.K. Valicenti, L.G. Gomella, M. Ismail Effect of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer Int J Radiat Oncol Biol Phys 42 1998 501 506
19. J.D. Cox, M.J. Gallagher, E.H. Hammond American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus statements on radiation therapy of prostate cancer guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy J Clin Oncol 17 2004 1155 1163
20. D.M. Nudell, G.D. Grossfeld, V.K. Weinberg Radiotherapy after radical prostatectomy treatment outcomes and failure patterns Urology 54 1999 1049 1057
21. S.L. Liauw, W.S. Webster, D.A. Pistenmaa Salvage radiotherapy for biochemical failure of radical prostatectomy a single-institution experience Urology 61 2003 1204 1210
22. C. Catton, M. Gospodarowicz, P. Warde Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate Radiother Oncol 59 2001 51 60
23. R.K. Valicenti, L.G. Gomella, M. Ismail Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma effect of early adjuvant radiation therapy on biochemical control Cancer 82 1998 1909 1914
24. J.A. Kalapurakal, C.F. Huang, M.M. Neriamparampil Biochemical disease-free survival following adjuvant and salvage irradiation after radical prostatectomy Int J Radiat Oncol Biol Phys 54 2002 1047 1054
25. F.A. Vicini, R.L. Ziaja, E.L. Kestin Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer Urology 54 1999 111 117